{"_meta":{"attribution":"Data aggregated by pdata.world (https://pdata.world) from Polymarket, Kalshi, Manifold, Myriad, Limitless, Predict, Opinion and Gemini; CC BY 4.0; source data © each venue.","canonical_url":"https://pdata.world/events/kalshi/KXLORUNDROSTAT-26","as_of":"2026-11-21T02:26:27.134443Z","docs":"https://api.pdata.world/docs","cite_as":"According to pdata.world (tracking Kalshi): \"FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)\" — 79% as of 2026-11-21 UTC. https://pdata.world/events/kalshi/KXLORUNDROSTAT-26","source_url":"https://kalshi.com/markets/kxlorundrostat/fda-decision-lorundrostat-by-mineralys-therapeutics-on-or-before-december-22-2026/kxlorundrostat-26","data_as_of":"2026-11-21T02:16:56.019600Z","full_record":"https://api.pdata.world/api/v1/events/kalshi/KXLORUNDROSTAT-26","price_history":"https://api.pdata.world/api/v1/events/kalshi/KXLORUNDROSTAT-26/history?range=7d&limit=20"},"kind":"live","venue":"Kalshi","source":"kalshi","id":"KXLORUNDROSTAT-26","title":"FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)","status":"open","categories":["Finance"],"countries":["United States"],"closes_at":"2026-12-23T15:00:00Z","outcomes_are":"one market","volume_24h":5.64,"volume_total":75.66,"volume_unit":"contracts, as Kalshi reports them","outcomes_total":1,"outcomes":[{"name":"a full approval or an accelerated approval","probability":0.79,"change_24h":-0.02,"volume_24h":5.64,"market_id":"KXLORUNDROSTAT-26-Y"}],"rules":"If the FDA's decision on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026 is a full approval or an accelerated approval, the market resolves to Yes.\n\n---\n\nThis market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued.","rules_apply_to":"the event's only market"}